Evidence map›Paper›PMID 36396800›Full record

ArticleCommunications biology2022

A lineage tree-based hidden Markov model quantifies cellular heterogeneity and plasticity.

Farnaz Mohammadi, Shakthi Visagan, Sean M Gross, Luka Karginov, J C Lagarde, Laura M Heiser, Aaron S Meyer

Abstract read
In one paragraph

Article in Communications biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. An efficient solution to Hidden Markov Models on trees with coupled branches.IEEE transactions on signal processing : a publication of the IEEE Signal Processing Society · 2025
    Article
  7. Article
  8. Article
  9. Live Cell Lineage Tracing of Dormant Cancer Cells.Advanced healthcare materials · 2023
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Farnaz MohammadiDepartment of Bioengineering, University of California, Los Angeles, CA, USA.ORCID 0000-0002-0197-4670
Shakthi VisaganDepartment of Bioengineering, University of California, Los Angeles, CA, USA.ORCID 0000-0001-9295-2188
Sean M GrossDepartment of Biomedical Engineering, Oregon Health & Science University, Portland, OR, USA.
Luka KarginovDepartment of Bioengineering, University of Illinois, Urbana Champaign, IL, USA.
J C LagardeDepartment of Bioengineering, University of California, Los Angeles, CA, USA.
Laura M HeiserDepartment of Biomedical Engineering, Oregon Health & Science University, Portland, OR, USA.ORCID 0000-0003-3330-0950
Aaron S MeyerDepartment of Bioengineering, University of California, Los Angeles, CA, USA. ameyer@ucla.edu.ORCID 0000-0003-4513-1840

Funding

OutreachU54HG008100 · NHGRI · OREGON HEALTH & SCIENCE UNIVERSITY · PI GRAY, JOE W., HEISER, LAURA MADELINE · 2014 to 2019
$10.5M
Understanding the Impact of Microscale and Nanoscale Heterogeneity and ResistanceU54CA209988 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI DEMIR, EMEK, HEISER, LAURA MADELINE · 2017 to 2021
$10.3M
Precision lung cancer therapy design through multiplexed adapter measurementU01CA215709 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI HAURA, ERIC B., MEYER, AARON SAMUEL · 2017 to 2021
$2.3M
NCI NIH HHS U01 CA215709NCI NIH HHS U54 CA209988NHGRI NIH HHS U54 HG008100
6 · The paper itself

Abstract

Individual cells can assume a variety of molecular and phenotypic states and recent studies indicate that cells can rapidly adapt in response to therapeutic stress. Such phenotypic plasticity may confer resistance, but also presents opportunities to identify molecular programs that could be targeted for therapeutic benefit. Approaches to quantify tumor-drug responses typically focus on snapshot, population-level measurements. While informative, these methods lack lineage and temporal information, which are particularly critical for understanding dynamic processes such as cell state switching. As new technologies have become available to measure lineage relationships, modeling approaches will be needed to identify the forms of cell-to-cell heterogeneity present in these data. Here we apply a lineage tree-based adaptation of a hidden Markov model that employs single cell lineages as input to learn the characteristic patterns of phenotypic heterogeneity and state transitions. In benchmarking studies, we demonstrated that the model successfully classifies cells within experimentally-tractable dataset sizes. As an application, we analyzed experimental measurements in cancer and non-cancer cell populations under various treatments. We find evidence of multiple phenotypically distinct states, with considerable heterogeneity and unique drug responses. In total, this framework allows for the flexible modeling of single cell heterogeneity across lineages to quantify, understand, and control cell state switching.

Indexed as

Cell Lineage

Identifiers

PMID36396800
PMCPMC9671968

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.